SLC1A2 and Alzheimer disease: Additionally, a subset of reactive astrocytes expressing higher levels of GLT-1, an abundant glutamate transporter, was identified in AD patients that had neuropathological changes consistent with AD but without dementia, unlike AD patients who had dementia (Kobayashi et al., 2018).